Human leukotriene (LT) A 4 hydrolase/aminopeptidase (LTA 4 H) is a bifunctional enzyme that converts the highly unstable epoxide intermediate LTA 4 into LTB 4 , a potent leukocyte activating agent, while the aminopeptidase activity cleaves and inactivates the chemotactic tripeptide Pro-Gly-Pro. Here, we describe high-resolution crystal structures of LTA 4 H complexed with LTA 4 , providing the structural underpinnings of the enzyme's unique epoxide hydrolase (EH) activity, involving Zn 2+ , Y383, E271, D375, and two catalytic waters. The structures reveal that a single catalytic water is involved in both catalytic activities of LTA 4 H, alternating between epoxide ring opening and peptide bond hydrolysis, assisted by E271 and E296, respectively. Moreover, we have found two conformations of LTA 4 H, uncovering significant domain movements. The resulting structural alterations indicate that LTA 4 entrance into the active site is a dynamic process that includes rearrangement of three moving domains to provide fast and efficient alignment and processing of the substrate. Thus, the movement of one dynamic domain widens the active site entrance, while another domain acts like a lid, opening and closing access to the hydrophobic tunnel, which accommodates the aliphatic tale of LTA 4 during EH reaction. The enzyme-LTA 4 complex structures and dynamic domain movements provide critical insights for development of drugs targeting LTA 4 H. is a 69-kDa cytosolic bifunctional zinc metalloenzyme that converts the transient epoxide LTA 4 (5S-5,6-oxido-7,9-trans-11,14-cis-eicosatetraenoic acid) into the dihydroxy acid LTB 4 (5S,12R-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid) via a unique epoxide hydrolase (EH) reaction (1). LTB 4 , a potent chemotactic and immune-activating agent, is implicated in acute and chronic inflammatory diseases (2, 3), cardiovascular disorders (4, 5), and carcinogenesis (6). In addition to its proinflammatory EH activity, LTA 4 H may also counteract inflammation by its aminopeptidase activity, which inactivates by cleavage another neutrophil attractant, the tripeptide Pro-Gly-Pro (PGP) (7). In addition, the fatty acid epoxide LTA 4 is also the key precursor for biosynthesis of lipoxins, a family of anti-inflammatory, proresolving lipid mediators (8). Hence, LTA 4 H is a checkpoint in lipid mediator biosynthesis that regulates both the initiation and resolution phases of inflammation.LTA 4 H consists of N-terminal, catalytic, and C-terminal domains whose interface delimits a deep cleft harboring an L-shaped pocket, with a wide polar arm that binds PGP and a narrow hydrophobic arm that is believed to accommodate LTA 4 (9). The elbow of the pocket includes H295, H299, and E318, which coordinate a Zn 2+ ion essential for both LTA 4 H activities.LTA 4 H is the only EH reported to form a nonvicinal distant 5,12 diol (10), requiring an atypical catalytic mechanism, the details of which have remained elusive in the absence of a crystal structure with bound substrate (11). Acquirement of an enzymesubstr...